Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

This study aimed to determine the mechanical stresses experienced by third-generation, balloon-expandable transcatheter aortic valves in the presence of aortic calcification, defined by an elevated Agatston score index for calcium. The device under investigation was the Edwards SAPIEN 3 valve (referred to as S3-TAV henceforth), a 26-mm commercial device. Five steps were undertaken. The first was the reconstruction of the three-dimensional (3D) computer-aided design (CAD) model of the device. The second was a simulation of the crimping and reopening process. The third was evaluating the crimping effect on leaflet stress and a comparison to an ideal condition. The fourth was a simulation of real clinical cases. Finally, the subsequent phase of the study entails the post-processing of the simulation results and a comparison with the follow-up data. A high-resolution micro-computed tomography scan was used to develop an accurate 3D geometric mesh of the stent and the valve. The material properties of the leaflets were derived from surgical bioprostheses; the material properties of the stents were based on those of cobalt-chromium. A series of simulations were conducted to assess the impact of systemic pressure loading on the structure. Stress was quantified through the application of finite element analyses. A stress analysis of the valve, conducted using exact geometry derived from high-resolution scans, revealed that peak stresses during the crimping phase were concentrated at the commissural tips, where the leaflets were attached. These regions were identified as the most likely sites for thrombosis and degeneration. The persistence of bulky calcifications following the device expansion results in the formation of paravalvular leakages (PVLs), which act as precursors to thrombosis and structural valve degeneration.

Download full-text PDF

Source
http://dx.doi.org/10.3791/67455DOI Listing

Publication Analysis

Top Keywords

third-generation balloon-expandable
8
material properties
8
valve
5
measuring stress
4
stress third-generation
4
balloon-expandable aortic
4
aortic valve
4
valve expansion
4
expansion study
4
study aimed
4

Similar Publications

Measuring Stress on a Third-Generation Balloon-Expandable Aortic Valve During Expansion.

J Vis Exp

July 2025

Department of Cardiothoracic Surgery, University of Cincinnati College of Medicine; Department of Cardiothoracic Surgery, Mayo Clinic, Rochester.

This study aimed to determine the mechanical stresses experienced by third-generation, balloon-expandable transcatheter aortic valves in the presence of aortic calcification, defined by an elevated Agatston score index for calcium. The device under investigation was the Edwards SAPIEN 3 valve (referred to as S3-TAV henceforth), a 26-mm commercial device. Five steps were undertaken.

View Article and Find Full Text PDF

Review Article: Contemporary Transcatheter Heart Valves for TAVI in Bicuspid Aortic Anatomy.

J Clin Med

April 2025

Groupe Cardio-Vasculaire Interventionnel, Clinique Pasteur, 45, Avenue de Lombez, 31000 Toulouse, France.

Bicuspid aortic valve (BAV) is the most common congenital heart disease, affecting 0.5-2% of the population and often leading to early aortic valve degeneration. While surgical aortic valve replacement (SAVR) remains the gold standard for treating severe bicuspid aortic stenosis (AS), transcatheter aortic valve implantation (TAVI) is emerging as a viable alternative in selected BAV anatomies.

View Article and Find Full Text PDF

Background: The choice of transcatheter aortic valve replacement (TAVR) prosthesis is crucial in optimizing short- and long-term outcomes. The objective of this study was to conduct a meta-analysis comparing outcomes of third-generation balloon-expandable valves (BEV) vs self-expanding valves (SEV).

Methods: Electronic databases were searched from inception to June 2023 for studies comparing third-generation BEV vs SEV.

View Article and Find Full Text PDF

Predictors and 5-Year Clinical Outcomes of Pacemaker After TAVR: Analysis From the PARTNER 2 SAPIEN 3 Registries.

JACC Cardiovasc Interv

June 2024

Division of Cardiology, Columbia University Irving Medical Center, NewYork-Presbyterian Hospital, New York, New York, USA. Electronic address:

Article Synopsis
  • A study on patients undergoing transcatheter aortic valve replacement (TAVR) with the SAPIEN 3 valve found that 12.5% required a permanent pacemaker (PPM) within 30 days post-procedure.
  • Predictors of needing PPM included factors like older age, pre-existing heart block, larger valve size, and deeper implantation.
  • Despite requiring a new PPM, these patients did not experience higher rates of death or hospitalization over 5 years, and factors like valve sizing may help lower PPM rates in the future.
View Article and Find Full Text PDF
Article Synopsis
  • Surgical mitral valve repairs may not hold up over time, leading to potential repeat surgeries; transcatheter mitral valve-in-ring (MViR) offers a new option for high-risk patients.
  • A study analyzed outcomes of MViR involving 820 patients, with most in poor heart function classes and significant mitral regurgitation; initial results showed a 30-day mortality rate of 8.3% and a 1-year rate of 22.4%.
  • At one year, MViR patients experienced improvements in heart function and reduced mitral regurgitation, but there were concerns about elevated pressure gradients and a 9.1% reintervention rate, affirming MViR as a viable
View Article and Find Full Text PDF